Calcimedica, Inc.
Clinical trials sponsored by Calcimedica, Inc., explained in plain language.
-
New drug shows promise for severe pancreatitis in early trial
Disease control CompletedThis study tested a new medicine called CM4620-IE in 21 people with severe pancreatitis and body-wide inflammation (SIRS). The goal was to see if the drug is safe and helps control the disease. Participants received either the drug plus standard care or standard care alone. The s…
Phase: PHASE2 • Sponsor: CalciMedica, Inc. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New drug shows promise against severe COVID-19 lung infection
Disease control CompletedThis study tested a drug called Auxora in 314 people with severe COVID-19 pneumonia. The goal was to see if it helps patients recover faster and reduces the need for breathing machines or death. Participants received either Auxora or a placebo through an IV over 48 hours, along w…
Phase: PHASE2 • Sponsor: CalciMedica, Inc. • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
New drug shows promise for speeding recovery in pancreatitis patients
Symptom relief CompletedThis study tested a drug called Auxora in 216 people with acute pancreatitis and a related body-wide inflammation (SIRS). Participants received either Auxora or a placebo for three days. The main goal was to see if the drug helped patients tolerate solid food sooner. The trial ai…
Phase: PHASE2 • Sponsor: CalciMedica, Inc. • Aim: Symptom relief
Last updated May 07, 2026 18:40 UTC